Phase I/II Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Conditions: Non Hodgkin Lymphoma; Mantle Cell Lymphoma Interventions: Biological: 8-Day Production of Car-T Cells; Biological: 12-Day Production of Car-T Cells Sponsor: Medical College of Wisconsin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials